
HCA Healthcare, Inc. company profile
$499.05−0.32%Close 13 Nov 2026 · Market value $107.1B
About HCA Healthcare, Inc.
HCA Healthcare, Inc. is a health care services company in the United States that operates hospitals and outpatient facilities. At December 31, 2025, it operated 179 general acute care hospitals, seven behavioral hospitals and four rehabilitation hospitals, along with 121 freestanding ambulatory surgery centers and 31 freestanding endoscopy centers. Its general acute care hospitals offer a full range of medical and surgical services, including inpatient, intensive, cardiac, diagnostic and emergency care, while its behavioral hospitals provide inpatient, partial hospitalization and outpatient mental health and substance abuse treatment. Its outpatient network also includes urgent care facilities, walk-in clinics, diagnostic and imaging centers, physician practices and home health agencies. The company receives payments from Medicare, Medicaid, managed care plans, private insurers and patients. Its facilities are located in 19 states and England.
A summary of the business section of the company's latest annual report, filed 10 Feb 2026.
Company facts
| Ticker | HCA · NYSE |
|---|
| Sector | Healthcare |
|---|
| Industry | Health Care Facilities |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 860730 |
|---|
| Latest annual report | 10-K, filed 10 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Samuel N. Hazen | CEO · Director | 2.2M · < 1% | Shares withheld for tax, 10 Feb 2026 |
|---|
| William R. Frist | Director · 10% owner | 416K · < 1% | Grant or award, 28 Apr 2026 |
|---|
| Jon M. Foster | EVP and COO | 308K · < 1% | Grant or award, 10 Feb 2026 |
|---|
| Michael S. Cuffe, M.D. | EVP and Chief Clinical Officer | 84.7K · < 1% | Shares withheld for tax, 10 Feb 2026 |
|---|
| Michael R. McAlevey | EVP & Chief Legal & Admin Off. | 38.2K · < 1% | Code J, 26 Aug 2026 |
|---|
| Robert J. Dennis | Director | 26.6K · < 1% | Grant or award, 29 Apr 2025 |
|---|
| Nancy-Ann DeParle | Director | 21.4K · < 1% | Grant or award, 28 Apr 2026 |
|---|
| Thomas F. Frist III | Director · 10% owner | 14.8K · < 1% | Code J, 4 Nov 2026 |
|---|
| Wayne J. Riley, M.D. | Director | 14.5K · < 1% | Grant or award, 28 Apr 2026 |
|---|
| Michael W. Michelson | Director | 11.7K · < 1% | Grant or award, 28 Apr 2026 |
|---|
| Andrea B. Smith | Director | 4.2K · < 1% | Grant or award, 28 Apr 2026 |
|---|
| Hugh F. Johnston | Director | 3.7K · < 1% | Grant or award, 28 Apr 2026 |
|---|
| John W. Chidsey, III | Director | 524 · < 1% | Grant or award, 28 Apr 2026 |
|---|
| Schlosser Michael J | EVP and Chief Clinical Officer | — | Open-market sale, 4 Nov 2026 |
|---|
| Marks Mike A | EVP and CFO | — | Code J, 2 Nov 2026 |
|---|
| Wyatt Christopher F. | SVP & Controller | — | Open-market sale, 11 Feb 2026 |
|---|
| Berres Jennifer | SVP & Chief Human Res. Officer | — | Open-market sale, 11 Feb 2026 |
|---|
| Rossitto Erica | SVP & Chief Nurse Executive | — | Shares withheld for tax, 10 Feb 2026 |
|---|
| Mosier Sammie S | SVP & Chief Nurse Executive | — | Shares withheld for tax, 13 Feb 2025 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
HCA in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.